SILVER SPRING
Idvynso cleared for HIV-1 in adults
- Sponsor
- Merck $MRK
- Drug
- Idvynso · doravirine/islatravir
- Indication
- HIV-1 infection in adults
FDA approved Idvynso, a two-drug single-tablet regimen of doravirine and islatravir, for HIV-1 treatment in adults.
What this means
Idvynso is a once-daily pill combining two HIV drugs that block the virus from multiplying by targeting different stages of its replication process. FDA approved Idvynso for adults with HIV-1, making it the first single-tablet regimen with this specific drug combination. This approval gives patients a simpler treatment option that may reduce the number of pills needed to manage their HIV.